New International PhD Program in Cancer Biology and Oncology 2020-2021

PhD at Institute of Oncology Research (IOR) means full immersion in a dynamic, challenging and intellectual community of students coming from different countries. The IOR provides high-level scientific education both for undergraduate students, experimental diploma thesis as well as graduate students. The PhD program, which includes seminars, lectures, classes and an annual retreat, is carried out...
More

EPFL, SUPSI and IOR receive a Swiss National Science Foundation (SNFS) grant within the NRP 78 “Covid-19” programme to develop a microfluidics device to detect SARS-CoV-2 virus

The project “Development of a microfluidic platform for real-time detection of SARS-CoV-2 virus based on multifunctional silica membrane biosensors” (MicroCoVSens) aims to realize a portable device for real-time detection of SARS-CoV-2 virus from saliva samples through minimal reagents consumption, without preparation requirements, at hand of non-specialist personnel. The group headed by Prof. Ber...
More

IOR researchers suggest that androgen-deprivation treatments for prostate cancer could protect men from COVID-19

The so-called "androgen-deprivation" treatments used in prostate cancer therapy may have a protective effect against COVID-19. A study conducted by the Istitute of Oncology Research (IOR, affiliated to USI) based on health data obtained from the Veneto region in Italy has observed a lower risk of developing the coronavirus disease for men subject to this type of therapy. The study, performed in co...
More

Tiziano Bernasocchi awarded “PhD in Life Sciences” from the University of Lausanne

Tiziano Bernasocchi, molecular biologist in the Prostate Cancer Genome group of Prof. Jean-Philippe Theurillat, successfully defended his Ph.D. on April 21st, 2020, from the University of Lausanne. He presented the work entitled: Dual Functions of SPOP and ERG Dictate Androgen Therapy Responses in Prostate Cancer.  The research work elucidates an enigmatic finding of comprehensive prostate canc...
More

Geniver El Tekle received the “PhD in Life Sciences” from the University of Lausanne

Geniver El Tekle successfully defended her Ph.D. thesis at the Institute of Oncology Research (IOR) in Bellinzona on April 20th, 2020. Her thesis entitled “ Functional Characterization and Therapeutic Implications of SPOP Mutations in Endometrial and Prostate Cancer” was carried out in the Functional Cancer Genomics group directed by Prof. Jean-Philippe Theurillat at the IOR.   The thesis focus...
More

IOR paves the way for the clinical development of a therapy against prostate cancer metastasis

An international group of researchers, led by Andrea Alimonti, Group Leader at the Institute of Oncology Research (IOR, affiliated to USI) and Professor at the USI Faculty of Biomedical Sciences and at ETH Zurich, has discovered a mechanism to recognise the cancer cells responsible for prostate cancer and selectively eliminate them. The study was published on April 6 by the Journal of Clinical Inv...
More